Cardiogenic shock

Cardiogenic shock is a critical medical emergency. It occurs when the heart cannot pump enough blood to meet the body's needs. This failure leads to inadequate blood flow to vital organs. When organs do not receive enough oxygen, they can begin to fail. This condition is extremely serious and difficult to fully reverse. However, starting treatment very early can improve a person's chances of recovery.

The mechanism of cardiogenic shock involves a drop in cardiac output. Cardiac output is the amount of blood the heart pumps per minute. When this falls, blood pressure can become severely low. This lack of perfusion, or blood flow, affects many different systems. For example, the brain may receive less oxygen, causing drowsiness or even a coma. The skin may feel cool, clammy, or mottled, a condition called cutis marmorata. This happens because the body uses vasoconstriction to redirect blood to essential organs. Additionally, fluid may build up in the lungs, a process known as pulmonary edema.

There are several primary causes for this type of shock. The most common cause is a heart attack, which is a myocardial infarction. During a heart attack, blood flow to the heart muscle is blocked. This often happens in the left anterior descending artery or the left main coronary artery. Other causes include arrhythmic issues, which are abnormal heart rhythms. Mechanical causes can also occur, such as heart valve problems or a ventricular outflow obstruction. In some rare cases, sudden depressurization, like in an aircraft, can release air bubbles into the bloodstream. This follows Henry's law and can lead to sudden heart failure.

Medical professionals use several diagnostic tools to understand the situation. An electrocardiogram, or ECG, helps assess heart muscle damage and rhythms. An echocardiogram uses sound waves to look at the heart's physical structure. This can reveal complications like a papillary muscle rupture or a septum rupture. Doctors may also use a pulmonary artery catheter for invasive hemodynamic monitoring. This tool measures pressures like the pulmonary capillary wedge pressure to show how severe the shock is. If the cause is an unknown cardiomyopathy, a biopsy might be performed. This involves taking a tiny sample of heart muscle for study.

Treatment begins with the goal of improving blood flow to the body. Doctors often use first-line medications like dobutamine or milrinone. These drugs help the heart muscle contract more effectively. If medications are not enough, mechanical circulatory support devices are used. An intra-aortic balloon pump is a common device. It uses a helium balloon in the aorta that inflates during diastole, the heart's resting phase. This helps decrease the pressure the heart must pump against. Another option is a left ventricular assist device, such as an Impella. This device acts as a pump to move blood from the left ventricle into the aorta.

For the most severe cases, doctors may use venous-arterial extra-corporeal membrane oxygenation, or ECMO. This is a complex circuit that replaces the heart's function. It drains blood from the venous system, adds oxygen, removes carbon dioxide, and returns it to the arterial system. ECMO is usually reserved for patients who do not respond to other treatments. These mechanical devices are not permanent solutions. Instead, they act as a bridge. They keep the patient stable while they wait for a definitive therapy, such as a heart transplant or surgery.

Despite medical advances, the statistics for cardiogenic shock remain high. It is estimated to complicate 5% to 10% of all heart attacks. The 30-day mortality rate after a heart attack is 40%. The 1-year mortality rate reaches 50%. However, mortality rates in the United States have been decreasing. This improvement is likely due to faster identification and newer treatment advances. When cardiogenic shock leads to multi-organ failure, the risk of death increases significantly.